Goodbody Health AGM to be held on August 9, 2022

Goodbody Health Inc. (AQSE: GDBY) has announced that further to its news release dated June 10, 2022, the Company has mailed its proxy materials, with instructions on how to attend and vote, to its shareholders of record as of July 5, 2022 for its annual general and special meeting to be held on August 9, 2022 at 9 am (Pacific time) at The Blue Building, Stubbs Lane, Beckington, Frome, BA11 6TE, United Kingdom.  The information circular dated July 8, 2022, forming part of the proxy materials, sets out full details of the Company’s intention to de-list from the Canadian Securities Exchange and to re-domicile the Company from the Province of British Columbia to Guernsey, subject to shareholder approval. The information circular and proxy materials will shortly be available at the Company’s website at www.goodbodyhealth.com.

Goodbody intends to retain its quote on the AQSE Growth Market in London and the OTCQB quote in the United States. Further announcements regarding the post-Continuation trading arrangements on the AQSE Growth Market will be made in due course.

Prior to the Continuation and the De-Listing, the Company intends to consolidate all of its issued and outstanding common shares on the basis of ten (10) pre-consolidation shares for one (1) post-consolidated share (the “Consolidation”).  The Company currently has 364,962,152 common shares issued and outstanding.  Following completion of the Consolidation, the Company would have approximately 36,496,215 common shares issued and outstanding.  The Company will also consolidate all warrants and Options to the same ratio. The Company currently has 36,603,461 options issued and outstanding.  Following completion of the Consolidation, the Company would have approximately 3,660,346 options issued and outstanding. The Company currently has 49,317,379 warrants issued and outstanding.  Following completion of the Consolidation, the Company would have approximately 4,931,737 warrants issued and outstanding. Any fractional common shares resulting from the Consolidation would be rounded to the nearest whole common share, with any fraction of 0.5 or above rounded up and any fraction of less than 0.5 rounded down.  Pursuant to the Company’s current articles, the Company’s board of directors can authorize the Consolidation by directors’ resolutions.  The Consolidation is subject to Canadian Securities Exchange approval.

The voting results from the Meeting regarding the Continuation will not affect the De-Listing or the Consolidation.

The Company’s proxy materials are also available on the Company’s SEDAR profile on www.sedar.com.

Click to view all articles for the EPIC:
Or click to view the full company profile:
Share on facebook
Facebook
Share on twitter
Twitter
Share on linkedin
LinkedIn
Goodbody Health Inc.

More articles like this

Goodbody Health Inc.

Goodbody Health appoints George Thomas as new CEO

Goodbody Health Limited (AQSE:GDBY) has announced that Marc Howells has resigned from the Board as Chief Executive Officer, with immediate effect.  The Company wishes to thank Marc for his contribution to the Company. George Thomas, an existing Executive

Goodbody Health Inc.

Good cholesterol may not protect against heart disease

For decades doctors have been telling their patients that high levels of HDL, otherwise known as “good cholesterol,” could protect them from heart disease. But a new study suggests that having a lot of so-called good cholesterol doesn’t

Goodbody Health Inc.

Andy Taylor’s terminal prostate cancer diagnosis

Heartbroken fans have shown their support for Duran Duran’s Andy Taylor after it emerged he’s battling cancer.  Bandmate Simon Le Bon broke the news on Sunday as he read out a letter from the guitarist and said Taylor will not

Goodbody Health Inc.

Symptoms of high cholesterol

High Cholesterol can be a silent development, making it all the more dangerous. But often, other parts of the body – like your feet or nails – can show some symptoms that may be indicative of this problem.

Goodbody Health Inc.

How to manage prediabetes and prevent diabetes

Prediabetes occurs when blood sugar levels are higher than normal but not quite at the level of diabetes. High blood sugar levels occur in prediabetes when the body does not properly respond to insulin (a hormone that allows cells to use

Goodbody Health Inc.

How to spot the symptoms of prostate cancer

Talking (and reading) about cancer can be difficult, but did you know that one in eight men will get prostate cancer at some point in their life? It’s the most common cancer in men, but some most men don’t

Goodbody Health Inc.

High Cholesterol: What it means and how to treat it

Have you had your lipid panel checked recently? Were you told you have high cholesterol? If so, you are among approximately 94 million adult Americans with cholesterol levels over normal ranges. This condition, referred to as dyslipidemia or hyperlipidemia,

Goodbody Health Inc.

Prostate cancer symptoms and treatment: What to check for

Bill Turnbull’s campaigning saved lives and encouraged “thousands and thousands” of men to come forward for prostate cancer testing, experts say. The broadcaster died from the disease, at the age of 66. When Turnbull revealed his diagnosis, in

Goodbody Health Inc.

Symptoms of prediabetes

Approximately 38% of adults and 28% of children in the United States have prediabetes, a health condition associated with abnormally high blood sugar levels.1 While blood sugar (glucose) levels are elevated in prediabetes, they are not high enough to be

Goodbody Health Inc.

Goodbody Health wins distribution contract

Goodbody Health announced that that it has signed a contract with Tasso Inc, the leading provider of convenient, clinical grade blood collection solutions, for the UK pharmacy and wellness market. Tasso produces a signature line of virtually painless

Goodbody Health Inc.

Goodbody Health signs distribution contract with Tasso

Goodbody Health Inc (AQSE:GDBY) has announced that it has signed a contract with Tasso Inc, the leading provider of convenient, clinical grade blood collection solutions, for the UK pharmacy and wellness market. Tasso produces a signature line of

Goodbody Health Inc.

Early detection and treatment can reverse pre-diabetes

Type 2 diabetes, in which the body doesn’t use insulin properly, is on the rise in the United States. There are more than 35 million people with the condition, and many are diagnosed when they are young, even

Goodbody Health Inc.

6 Simple steps to a happy, healthy heart

Heart health is really important, but it’s not just about taking the right supplements. It’s important to follow this emotional health advice, too It is interesting how many people shun emotional health advice. They believe that heart health requires more

Goodbody Health Inc.

Kenny Logan: Rugby hero reveals prostate cancer shock

Former Scotland international Kenny Logan has revealed his “huge shock” at being diagnosed with prostate cancer. Logan, who won 70 caps for his country, was given the news in February. “It’s hard because when you’re told you’ve got

Goodbody Health Inc.

Unusual signs and symptoms of raised cholesterol

Many people only become aware for the first time that they have a high cholesterol level, when they are admitted to hospital with a heart attack Unfortunately, there are usually very few clinical signs of raised cholesterol. However,

Goodbody Health Inc.

Understanding prediabetes

Prediabetes is a diagnosis where your blood sugar levels are higher than normal, but not high enough to be considered diabetes. There are a lot of misconceptions and a general lack of concern around this condition because most

Goodbody Health Inc.

Goodbody Health H1 revenue 52% higher than 2021

Goodbody Health Inc (AQSE:GDBY) has announced its half year 2022 unaudited Interim Financial Statements for the six months to 30 June 2022. The revenue at £7.40m was £2.55m higher than the comparative period in 2021. As anticipated, the

No more posts to show